371 related articles for article (PubMed ID: 26153141)
1. Engineering immunity in the mucosal niche against sexually transmitted infections.
Ramanathan R; Woodrow K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):107-22. PubMed ID: 26153141
[TBL] [Abstract][Full Text] [Related]
2. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.
Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells and vaccine design for sexually-transmitted diseases.
Duluc D; Gannevat J; Joo H; Ni L; Upchurch K; Boreham M; Carley M; Stecher J; Zurawski G; Oh S
Microb Pathog; 2013 May; 58():35-44. PubMed ID: 23201532
[TBL] [Abstract][Full Text] [Related]
4. Female genital tract immunity: distinct immunological challenges for vaccine development.
Naz RK
J Reprod Immunol; 2012 Jan; 93(1):1-8. PubMed ID: 22154945
[TBL] [Abstract][Full Text] [Related]
5. [Specific mucosal immunity in the female reproductive tract: protection against infectious diseases and regulation of fertility (part 2)].
Zivný J; Sterzl I
Ceska Gynekol; 2003 Jul; 68(4):254-8. PubMed ID: 14515648
[TBL] [Abstract][Full Text] [Related]
6. Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract.
Keller MJ; Herold BC
Am J Reprod Immunol; 2006; 56(5-6):356-63. PubMed ID: 17076680
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of sexually transmitted infection-induced inflammation in women: implications for HIV risk.
Mwatelah R; McKinnon LR; Baxter C; Abdool Karim Q; Abdool Karim SS
J Int AIDS Soc; 2019 Aug; 22 Suppl 6(Suppl Suppl 6):e25346. PubMed ID: 31468677
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses.
Kaushic C; Roth KL; Anipindi V; Xiu F
J Reprod Immunol; 2011 Mar; 88(2):204-9. PubMed ID: 21296427
[TBL] [Abstract][Full Text] [Related]
9. Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens.
Wira CR; Fahey JV; Rodriguez-Garcia M; Shen Z; Patel MV
Am J Reprod Immunol; 2014 Aug; 72(2):236-58. PubMed ID: 24734774
[TBL] [Abstract][Full Text] [Related]
10. Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections.
Brotman RM; Ravel J; Bavoil PM; Gravitt PE; Ghanem KG
Vaccine; 2014 Mar; 32(14):1543-52. PubMed ID: 24135572
[TBL] [Abstract][Full Text] [Related]
11. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells.
Quayle AJ
J Reprod Immunol; 2002; 57(1-2):61-79. PubMed ID: 12385834
[TBL] [Abstract][Full Text] [Related]
12. Anatomic and hormonal changes in the female reproductive tract immune environment during the life cycle: implications for HIV/STI prevention research.
Venkatesh KK; Cu-Uvin S
Am J Reprod Immunol; 2014 Jun; 71(6):495-504. PubMed ID: 24832617
[TBL] [Abstract][Full Text] [Related]
13. Secreted mucosal antimicrobials in the female reproductive tract that are important to consider for HIV prevention.
Ghosh M
Am J Reprod Immunol; 2014 Jun; 71(6):575-88. PubMed ID: 24754244
[TBL] [Abstract][Full Text] [Related]
14. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunity in the female genital tract, HIV/AIDS.
Reis Machado J; da Silva MV; Cavellani CL; dos Reis MA; Monteiro ML; Teixeira Vde P; Miranda Corrêa RR
Biomed Res Int; 2014; 2014():350195. PubMed ID: 25313360
[TBL] [Abstract][Full Text] [Related]
16. Chemokine-mediated immune responses in the female genital tract mucosa.
Deruaz M; Luster AD
Immunol Cell Biol; 2015 Apr; 93(4):347-54. PubMed ID: 25776842
[TBL] [Abstract][Full Text] [Related]
17. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections.
Hickey DK; Patel MV; Fahey JV; Wira CR
J Reprod Immunol; 2011 Mar; 88(2):185-94. PubMed ID: 21353708
[TBL] [Abstract][Full Text] [Related]
18. Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract.
Rosenthal KL; Gallichan WS
Semin Immunol; 1997 Oct; 9(5):303-14. PubMed ID: 9327525
[TBL] [Abstract][Full Text] [Related]
19. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.
Kaul R; Pettengell C; Sheth PM; Sunderji S; Biringer A; MacDonald K; Walmsley S; Rebbapragada A
J Reprod Immunol; 2008 Jan; 77(1):32-40. PubMed ID: 17395270
[TBL] [Abstract][Full Text] [Related]
20. Multiplex immunoassay of lower genital tract mucosal fluid from women attending an urban STD clinic shows broadly increased IL1ß and lactoferrin.
Spear GT; Kendrick SR; Chen HY; Thomas TT; Bahk M; Balderas R; Ghosh S; Weinberg A; Landay AL
PLoS One; 2011 May; 6(5):e19560. PubMed ID: 21572958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
